Multigenerational Care for At-Risk Family Members of Patients with Inherited Cardiomyopathies
From Robin Bacho
- Introduction & Case Presentation by Moderator: Wilson Tang, MD
- Genetic Evaluation of At-Risk Family Members: Joseph Liu
- Management of At-Risk Families with Hypertrophic Cardiomyopathy: Milind Desai, MD
- Symptomatic Evaluation for Family Members: J. Emanuel Finet, MD
- Imaging Evaluation for At-Risk Family Members: Jay Ramchand, MD PhD
- Arrhythmogenic Evaluation for At-Risk Family Members: Mandeep Bhargava, MD
- Considerations for Screening and Genetic Testing for At-Risk Children: Shahnawaz Amdani, MD
- Describe what clinical screening methods are appropriate for relatives of patients with cardiomyopathies.
- Identify what can be achieved with genetic diagnostic tests.
- Discuss the next steps for genotype-positive and genotype-negative patients.
This online series is designed for physicians, allied health practitioners and students interested in complex cardiovascular and thoracic conditions.
The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are Free of commercial bias.
The following faculty has indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest: Mandeep Bhargava, MD, Joseph Liu, MS, Milind Desai, MD, Jay Ramchand, MD, Shahnawaz Amdani, MD, Christina M Rigelsky.
The following faculty has indicated that they may have a relationship, which in the context of their presentation(s) could be perceived as a potential conflict of interest: Eric E Roselli, MD, Activity Director: Abbott - Teaching and Speaking. Cook Medical - Teaching and Speaking. Cryolife, Inc. -Consulting. Edwards Lifesciences - Teaching and Speaking. LivaNova, PLC - Consulting, Teaching and Speaking. Medtronic - Consulting. Terumo - Teaching and Speaking. W.L. Gore & Associates - Consulting. Wai Hong Wilson Tang, MD: American Board of Internal Medicine - Other activities from which remuneration is received or expected: Exam writing committee. Cardiol Therapeutics Inc - Consulting. Genomics PLC - Consulting. Owkin, Inc - Consulting. PreCardia, Inc - Consulting. Relypsa Pharmaceuticals - Consulting. Sequana Medical - Consulting. SpringerNature - Other activities from which remuneration is received or expected: Editorship. J. Emanuel Finet, MD: Wolters-Kluwer - Consulting. Mardil Medical, Inc. - Consulting.
For further information about this activity, contact Katie Breznai at email@example.com